Target Price | $205.19 |
Price | $176.33 |
Potential | 16.36% |
Number of Estimates | 27 |
27 Analysts have issued a price target Texas Instruments 2026 . The average Texas Instruments target price is $205.19. This is 16.36% higher than the current stock price. The highest price target is $284.00 61.06% , the lowest is $130.00 26.27% . | |
A rating was issued by 38 analysts: 13 Analysts recommend Texas Instruments to buy, 21 to hold and 4 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Texas Instruments stock has an average upside potential 2026 of 16.36% . Most analysts recommend the Texas Instruments stock at Hold. |
29 Analysts have issued a sales forecast Texas Instruments 2025 . The average Texas Instruments sales estimate is $17.1b . This is 9.42% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $18.9b 20.61% , the lowest is $16.3b 4.01% .
This results in the following potential growth metrics:
2024 | $15.6b | 10.72% |
---|---|---|
2025 | $17.1b | 9.42% |
2026 | $19.4b | 13.40% |
2027 | $21.7b | 11.60% |
2028 | $25.2b | 16.31% |
2029 | $26.0b | 3.05% |
13 Analysts have issued an Texas Instruments EBITDA forecast 2025. The average Texas Instruments EBITDA estimate is $8.0b . This is 15.99% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $9.2b 33.26% , the lowest is $7.2b 3.44% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $6.9b | 19.23% |
---|---|---|
2025 | $8.0b | 15.99% |
2026 | $9.9b | 23.78% |
2027 | $10.9b | 10.06% |
2024 | 44.25% | 9.53% |
---|---|---|
2025 | 46.91% | 6.01% |
2026 | 51.20% | 9.15% |
2027 | 50.49% | 1.39% |
29 Texas Instruments Analysts have issued a net profit forecast 2025. The average Texas Instruments net profit estimate is $4.9b . This is 3.94% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $6.0b 26.92% , the lowest is $4.2b 10.38% .
This results in the following potential growth metrics and future Net Margins:
2024 | $4.7b | 26.45% |
---|---|---|
2025 | $4.9b | 3.94% |
2026 | $6.3b | 27.41% |
2027 | $7.4b | 18.07% |
2028 | $10.5b | 41.38% |
2029 | $10.5b | 0.30% |
2024 | 30.29% | 17.62% |
---|---|---|
2025 | 28.77% | 5.01% |
2026 | 32.32% | 12.34% |
2027 | 34.20% | 5.82% |
2028 | 41.57% | 21.55% |
2029 | 40.46% | 2.67% |
29 Analysts have issued a Texas Instruments forecast for earnings per share. The average Texas Instruments EPS is $5.40 . This is 3.85% higher than earnings per share in the financial year 2024. The highest EPS forecast is $6.60 26.92% , the lowest is $4.66 10.38% .
This results in the following potential growth metrics and future valuations:
2024 | $5.20 | 26.45% |
---|---|---|
2025 | $5.40 | 3.85% |
2026 | $6.89 | 27.59% |
2027 | $8.13 | 18.00% |
2028 | $11.50 | 41.45% |
2029 | $11.53 | 0.26% |
Current | 33.93 | 39.11% |
---|---|---|
2025 | 32.63 | 3.83% |
2026 | 25.61 | 21.51% |
2027 | 21.69 | 15.31% |
2028 | 15.34 | 29.28% |
2029 | 15.29 | 0.33% |
Based on analysts' sales estimates for 2025, the Texas Instruments stock is valued at an EV/Sales of 9.77 and an P/S ratio of 9.37 .
This results in the following potential growth metrics and future valuations:
Current | 10.69 | 16.96% |
---|---|---|
2025 | 9.77 | 8.59% |
2026 | 8.62 | 11.82% |
2027 | 7.72 | 10.40% |
2028 | 6.64 | 14.02% |
2029 | 6.44 | 2.95% |
Current | 10.26 | 14.59% |
---|---|---|
2025 | 9.37 | 8.61% |
2026 | 8.27 | 11.82% |
2027 | 7.41 | 10.40% |
2028 | 6.37 | 14.02% |
2029 | 6.18 | 2.96% |
Texas Instruments...
Analyst | Rating | Action | Date |
---|---|---|---|
Truist Securities |
Hold
➜
Hold
|
Unchanged | Jan 24 2025 |
Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jan 24 2025 |
Benchmark |
Buy
➜
Buy
|
Unchanged | Jan 24 2025 |
Mizuho |
Neutral
➜
Neutral
|
Unchanged | Jan 24 2025 |
Cantor Fitzgerald |
Neutral
➜
Neutral
|
Unchanged | Jan 24 2025 |
Rosenblatt |
Buy
➜
Buy
|
Unchanged | Jan 21 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Jan 17 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Truist Securities:
Hold
➜
Hold
|
Jan 24 2025 |
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Jan 24 2025 |
Unchanged
Benchmark:
Buy
➜
Buy
|
Jan 24 2025 |
Unchanged
Mizuho:
Neutral
➜
Neutral
|
Jan 24 2025 |
Unchanged
Cantor Fitzgerald:
Neutral
➜
Neutral
|
Jan 24 2025 |
Unchanged
Rosenblatt:
Buy
➜
Buy
|
Jan 21 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Jan 17 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.